ConductScience.org, home

Paper38965321

Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020.

Vision Loss Expert Group of the Global Burden of Disease Study and 1 other. Eye (Lond), 2024. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020. Papers, record 38965321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38965321

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020.
PubMed
Journal
Eye (Lond)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Meta-Analysis, Systematic Review
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
12.89, provisional
iCite
Revised in PubMed
2026-05-18
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vision Loss Expert Group of the Global Burden of Disease StudyGroup
2GBD 2019 Blindness and Vision Impairment CollaboratorsGroup

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BlindnessMajor topic
Global HealthMajor topic
Macular DegenerationMajor topic
Persons with Visual DisabilitiesMajor topic
Vision, LowMajor topic
Aged
Humans
Prevalence
Visual Acuity
Middle Aged
Aged, 80 and over

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128209587Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration.Genome Res2017https://conductscience.org/library/papers/28209587PubMed
233607016The Lancet Global Health Commission on Global Eye Health: vision beyond 2020.Lancet Glob Health2021https://conductscience.org/library/papers/33607016PubMed
317184527Quality of life in age-related macular degeneration: a review of the literature.Health Qual Life Outcomes2006https://conductscience.org/library/papers/17184527PubMed
433275950Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.Lancet Glob Health2021https://conductscience.org/library/papers/33275950PubMed
530303083Age-related macular degeneration.Lancet2018https://conductscience.org/library/papers/30303083PubMed
627864248The Challenge of Universal Eye Health in Latin America: distributive inequality of ophthalmologists in 14 countries.BMJ Open2016https://conductscience.org/library/papers/27864248PubMed
735610969Update of a Simple Model to Calculate the Annual Global Productivity Loss Due to Blindness and Moderate and Severe Vision Impairment.Ophthalmic Epidemiol2023https://conductscience.org/library/papers/35610969PubMed
835125538Access to eye care during the COVID-19 pandemic, India.Bull World Health Organ2022https://conductscience.org/library/papers/35125538PubMed
936890535Cost consequences of task-shifting intravitreal injections from physicians to nurses in a tertiary hospital in Norway.BMC Health Serv Res2023https://conductscience.org/library/papers/36890535PubMed
1032679112Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study.Lancet2020https://conductscience.org/library/papers/32679112PubMed
1129981738Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections.Am J Ophthalmol2018https://conductscience.org/library/papers/29981738PubMed
1230928983Same-Day Bilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections: Experience of a Large Canadian Retina Center.Ophthalmologica2019https://conductscience.org/library/papers/30928983PubMed
1321609239A global survey of low vision service provision.Ophthalmic Epidemiol2011https://conductscience.org/library/papers/21609239PubMed
1433275949
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.
Lancet Glob Health2021https://conductscience.org/library/papers/33275949PubMed
1529032195Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.Lancet Glob Health2017https://conductscience.org/library/papers/29032195PubMed
1617021318Ranibizumab for neovascular age-related macular degeneration.N Engl J Med2006https://conductscience.org/library/papers/17021318PubMed
1731266777Rapid Assessment of Avoidable Blindness: looking back, looking forward.Br J Ophthalmol2019https://conductscience.org/library/papers/31266777PubMed
1837865470Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.Lancet2023https://conductscience.org/library/papers/37865470PubMed
1927716253Nurse-administered intravitreal injections of anti-VEGF: study protocol for noninferiority randomized controlled trial of safety, cost and patient satisfaction.BMC Ophthalmol2016https://conductscience.org/library/papers/27716253PubMed
2032821853Strengthening the integration of eye care into the health system: methodology for the development of the WHO package of eye care interventions.BMJ Open Ophthalmol2020https://conductscience.org/library/papers/32821853PubMed

See all 22 referencesDownload CSV of references

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
42795729From Trials to Treatment: Current Evidence Supporting Faricimab Use in nAMD and DME.J Clin Med2026https://conductscience.org/library/papers/42795729PubMed
42741500Decoding the Bone-Eye Axis: Machine Learning for Age-Related Macular Degeneration Risk Prediction.Cyborg Bionic Syst2026https://conductscience.org/library/papers/42741500PubMed
42739742The Eight-Chop Technique in Nonagenarian Patients: Real-World Intraoperative and Postoperative Outcomes.J Clin Med2026https://conductscience.org/library/papers/42739742PubMed
42666877Trends and disparities of vision impairment in Mexico from 1990 to 2023: a comparative analysis with Latin America and the Caribbean based on the Global Burden of Disease Study 2023.Lancet Reg Health Am2026https://conductscience.org/library/papers/42666877PubMed
42445785Metabolic vulnerability, genetic susceptibility, and incident age-related eye diseases: a prospective cohort study.Front Nutr2026https://conductscience.org/library/papers/42445785PubMed
42207296Cell therapy for age-related macular degeneration.Mamm Genome2026https://conductscience.org/library/papers/42207296PubMed
42171426Patient Preferences for the PRIMA Retinal Prosthesis for Vision Restoration for Dry Age-Related Macular Degeneration: An International Survey Study.Transl Vis Sci Technol2026https://conductscience.org/library/papers/42171426PubMed
42113424Real-World Persistence with Anti-VEGF Therapy in Neovascular Age-related Macular Degeneration.Ophthalmol Ther2026https://conductscience.org/library/papers/42113424PubMed
42112359A new perspective on AMD pathogenesis: a sequential Factor H-centered view of complement dysregulation.Front Immunol2026https://conductscience.org/library/papers/42112359PubMed
42106887Prevalence of macular disorders assessed by OCT in adults 45 years and older from Parintins - the Brazilian Amazon Region Eye Survey (BARES).Int J Retina Vitreous2026https://conductscience.org/library/papers/42106887PubMed
42074899Advances in Gene Therapy for Age-Related Macular Degeneration: A Narrative Review.J Clin Med2026https://conductscience.org/library/papers/42074899PubMed
42038919Narrative Review of Artificial Intelligence in Ophthalmic Disease Detection : Artificial Intelligence in Ophthalmic Diseases Detection.Galen Med J2025https://conductscience.org/library/papers/42038919PubMed
41893888Global burden of age-related macular degeneration: Trends, regional disparities, and projections from the Global Burden of Disease study 2021.Graefes Arch Clin Exp Ophthalmol2026https://conductscience.org/library/papers/41893888PubMed
41876676The Royal College of Ophthalmologists National Ophthalmology Database age-related macular degeneration (AMD) audit: report 1, associations with socio-economic deprivation in neovascular AMD.Eye (Lond)2026https://conductscience.org/library/papers/41876676PubMed
41873297Intestinal Microbiome of Newly Diagnosed Patients With Neovascular Age-Related Macular Degeneration: A 16S rRNA Gene Sequencing Study.Cureus2026https://conductscience.org/library/papers/41873297PubMed
41868220Prevalence, incidence and risk factors of visual disability in patients with exudative age-related macular degeneration: a nationwide population-based study in Korea.Front Med (Lausanne)2026https://conductscience.org/library/papers/41868220PubMed
41788542Fibrotic scarring prevents optic nerve regeneration despite preserved axonal growth potential in adult killifish.Front Neurosci2026https://conductscience.org/library/papers/41788542PubMed
41705769Tobacco-Attributable Age-Related Macular Degeneration Vision Impairment in Japan: A National and Prefecture-Level Analysis From 1990 to 2040.Transl Vis Sci Technol2026https://conductscience.org/library/papers/41705769PubMed
41620804Global burden and cross-country inequalities of age-related eye diseases from 1990 to 2021: a comprehensive analysis of temporal trends and socioeconomic disparities.Eye Vis (Lond)2026https://conductscience.org/library/papers/41620804PubMed
41533907Levodopa Suppresses Choroidal Neovascularization Through a Tyrosinase-Dependent Dual Mechanism.Invest Ophthalmol Vis Sci2026https://conductscience.org/library/papers/41533907PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38965321

GET https://conductscience.org/api/papers/v1/38965321/references?page=2